Title |
Prostate cancer screening in Brazil: should it be done or not?
|
---|---|
Published in |
International Brazilian Journal of Urology, January 2016
|
DOI | 10.1590/s1677-5538.ibju.2015.0709 |
Pubmed ID | |
Authors |
Wilson F. S. Busato, Gilberto L. Almeida |
Abstract |
The use of PSA in the screening, detection and prognosis of prostate cancer (PCa) has revolutionized the diagnosis and treatment of this disorder with an increase in detection rates and PCa organ-confined. Despite these benefits and ease of implementation, tracking PCa remains a matter of great controversy. We conducted a literature review and demographic and epidemiological data in Brazil feeling to assess the current state of screening and whether there is justification for population programs. the diferences are valued between developed and underdeveloped countries as the incidence, mortality, screening and access to health. an analysis of the advantages and disadvantages of screening is made as well as a critical analysis of existing studies on screening and some recommendations on a rational screening. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 3% |
Unknown | 38 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 21% |
Student > Master | 5 | 13% |
Researcher | 5 | 13% |
Professor > Associate Professor | 3 | 8% |
Student > Ph. D. Student | 3 | 8% |
Other | 6 | 15% |
Unknown | 9 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 28% |
Biochemistry, Genetics and Molecular Biology | 4 | 10% |
Agricultural and Biological Sciences | 3 | 8% |
Unspecified | 2 | 5% |
Chemistry | 2 | 5% |
Other | 5 | 13% |
Unknown | 12 | 31% |